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Abstract
Background: Change in knee cartilage volume is frequently used as a proxy for change in knee joint space width
over time, but longitudinal data on these associations is limited. We aimed to determine whether change in knee
cartilage volume, new or worsening meniscal extrusion (ME), meniscal tears and cartilage defects over 2.4 years
correlated with change in joint space width (JSW) over 5 years in older community dwelling adults.
Methods: Participants (n = 153) had their right knee imaged using MR imaging and x-ray at baseline, and after
2.4 years (MRI) and 5 years (x-ray). Cartilage volume, cartilage defects, meniscal extrusions and meniscal tears were
assessed on sagittal T1-weighted fat-suppressed MRI. JSW was assessed using standard fixed semi-flexed view
radiographs, and scored on those with adequate alignment.
Results: Participants were 51–79 (mean 62) years old; 48 % were female. Cartilage volume reduced over time
(medial −134 ± 202 μL/year, lateral −106 ± 165 μL/year, p < 0.001), as did JSW (medial −0.05 ± 0.16 mm/year,
lateral −0.12 ± 0.24 mm/year, p < 0.001). In multivariable analysis, the only consistent predictor of change in JSW was
new or worsening ME (medial tibia R2 3.1 %, p = 0.031; medial femur R2 3.2 %, p = 0.024); change in cartilage volume
correlated with change in JSW laterally (R2 4.8 %, p = 0.007) and was borderline medially (R2 2.2 %, p = 0.064); there was
no association for meniscal tears or cartilage defects. The magnitude of these associations were similar albeit
somewhat greater for ME in participants with radiographic OA (R2 6.2 %, p = 0.017).
Conclusion: Change in ME and cartilage volume weakly predict change in JSW, but the vast majority of the variation
remains unexplained. Since MRI examines cartilage directly while radiographs examine it indirectly, these results cast
doubt on the validity of using JSW as a proxy measure of cartilage loss.
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Background
Osteoarthritis (OA) is a major cause of pain and func-
tional limitations and disability worldwide [1]. Diagnosis is
based on a combination of symptoms, clinical signs and
radiographic abnormalities [2]. Change in joint space
width (JSW) at the tibiofemoral joint has historically been
considered a good measure of change in cartilage volume.
It is currently the gold standard for assessing osteoarthritis
disease modification in clinical trials [3], and is mandated
by the Food and Drug Administration and European
Medications Agency as a proxy endpoint to determine
efficacy of disease modifying osteoarthritis drugs. In cross-
sectional studies, cartilage volume assessed by magnetic
resonance imaging (MRI) and JSW as assessed by radio-
graph are strongly correlated. However, JSW is also associ-
ated with meniscal pathology [4–7], and cartilage defects
[8], suggesting that multiple abnormalities contribute to
narrowing of joint space width (JSW) over time. The
presence of radiographic OA also predicts patients who
lose cartilage faster; this has implications for participant
selection in clinical trials [9, 10].
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A key remaining question is whether radiographic
JSW is the most appropriate measure for assessing
change in knee OA over time. Some studies have shown
significant structural change at the tibiofemoral joint over
time, such as trials involving glucosamine, doxycycline
and chondroitin [11–14]. However, in a trial investigating
the effect of risedronate on OA progression, there was
minimal change in the placebo arm over 2 years, despite
large numbers of patients and state of the art protocols
[15]. MRI-based cartilage loss has greater sensitivity to
change [16–18]; than change in radiographic JSW [19].
However, these assessments come from different cohorts;
there is limited longitudinal data comparing change in ra-
diographs with change in MRI within cohorts. Two stud-
ies reported weak but statistically significant correlation
between changes in JSW and cartilage volume at 1 year in
OA cohorts, using the fixed-flexion radiographic
techniques [17, 20]. Both Cicuttini and Raynauld reported
no correlation between x-ray change and cartilage
volume change on MRI over 2 years, using different
methodologies: standing protocol radiographs [21]
and a fluoroscopically guided AP semiflexed protocol
[22]. Hunter et al [23] assessed predictive value of
cartilage score on change in medial JSN in patients
with symptomatic knee OA over 30 months, using
fluoroscopic positioning and fixed flexion. They found
that cartilage score contributed to change in JSN
beyond age sex and BMI, but that most of the
variability in JSN remained unexplained [23]. Since
MRI has been directly validated for cartilage volume
measurement, this raises the possibility that JSW is not a
sufficiently adequate measure of cartilage to qualify it for
use as an outcome measure in clinical trials.
Moreover, data in the literature also reported that
meniscal position and cartilage morphology score also
contribute to variance in JSW [7, 23]. However, to our
knowledge there have been no prospective studies which
have determined the quantitative contribution of menis-
cal extrusion to narrowing of JSW over a period as long
as 5 years. Therefore, this study aimed to determine
whether change in cartilage volume and other structural
factors, including new or worsening meniscal extrusion
(ME), worsening meniscal tears, and worsening cartilage
defects over 2.4 years predicted change in JSW over
5 years in participants from a randomly selected cohort
of community dwelling older adults with and without
radiographic OA.
Methods
Study design and setting
The Tasmanian Older Adult Cohort (TASOAC) study is
an ongoing prospective population–based study in
southern Tasmania, Australia, which began in 2002.
Study participants
Men and women aged 50–80 years were randomly
selected from the roll of electors in southern Tasmania
(population 229,000), a comprehensive population listing,
using sex-stratified simple random sampling without
replacement (response rate 57 %). Permission to access
the roll of electors was granted by the Australian Electoral
Commission. Persons were excluded if they were institu-
tionalized, or had contraindications to MRI. The study
was approved by the Southern Tasmanian Health and
Medical Human Research Ethics Committee, and written
informed consent was obtained from all participants.
Baseline measurements (Phase 1) were conducted from
April 2002 to September 2004. Follow up data (Phase 2
and 3) was collected 2.4 (range 1.7 to 2.9) and 5 years
(range 4.6 to 5.9) later.
The current study consists of a sample of 153
participants who had data for x-rays and MRI at
baseline and follow-up with adequately aligned radio-
graphs (see Table 1).
Outcome measures
Knee radiographs
Standing anteroposterior semiflexed right knee radio-
graphs with 10–15° of fixed knee flexion were performed
at baseline and after 5 years. Radiographs were viewed
on Osiris software (University Hospital of Geneva,
Switzerland) and scored paired by one investigator (JH,
after instruction from GJ), blinded to MRI data but not
to chronological order. Measurements of the minimum
JSW (mJSW) at the lateral and medial compartment were
performed to the nearest 0.1 mm, using 200 % magnifica-
tion and a digital calliper in the image processing package,
and enhancement to improve cortical demarcation. mJSW
was determined as the narrowest, non-osteophytic space
of the lateral and medial compartments of the right knee
using a modified version of the method of Lequesne [24],
and using bony margins as described by Buckland-Wright.
[25] Briefly, the femoral boundaries were the distal convex
margin of the femoral condyles, and the tibial boundaries
the bright radiodense band of the subchondral cortex of
the tibia. The reader selected a minimum of five points in
each compartment, with the smallest reading used.
This technique is similar to the “calculated minimum”
technique, which is more accurate than measurement of
the narrowest site using visual assessment alone [26].
Intraclass correlation (ICC) was excellent, ranging from
0.92–0.99 in a random sample of 20 participants separated
in time.
In the absence of fluoroscopic guidance, radiographs
were limited to those which were well aligned (67 % of
those with films at both time points) [27], defined as
tibial inter-rim distance of the medial tibial plateau
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varying by ≤2 mm between films, measured at the
midpoint of the medial compartment.
X-rays were scored individually for osteophytes and nar-
rowing of JSW on a scale of 0–3 (0 = normal, 3 = severe)
according to the Osteoarthritis Research Society Inter-
national (OARSI) atlas [28] as previously described [29].
Intraobserver repeatability was acceptable (ICCs of 0.65 to
0.85 in 40 participants) [29]. The presence of radiographic
OA was defined as any score of ≥1.
Magnetic resonance imaging
Magnetic resonance imaging (MRI) of the right knee
was acquired using a 1.5 Tesla whole-body MRI unit
(Picker, Cleveland, OH, USA) using a commercial
transmit-receive extremity coil.
Tibial cartilage volume was assessed at baseline and
follow up by a trained observer on Osiris software as
previously described [30, 31] using T1-weighted fat
suppressed 3-dimensional gradient recall acquisition in
the steady state, flip angle 55°, repetition time 58 msec,
echo time 12 msec, field of view 16 cm, 60 partitions,
512 × 512–pixel matrix, acquisition time 11 min 56 s,
and 1 acquisition. Sagittal images were obtained at a par-
tition thickness of 1.5 mm and in-plane resolution of
0.31 × 0.31 mm (512 × 512 pixels). The volumes of indi-
vidual cartilage plates (medial tibia and lateral tibia) were
isolated from the total volume by manually drawing
disarticulation contours around the cartilage boundaries
on a section by section basis (see Fig. 1 for an image of
representative segmentation). These data were then re-
sampled by means of bilinear and cubic interpolation
(area of 312 × 312 mm and 1.5 mm thickness, continu-
ous sections) for the final 3-D rendering. The coefficient
of variation (CV) was 2.1 % for the medial tibia and
2.2 % for the lateral tibia [30].
Femoral cartilage volume was determined by means
of image processing on an independent workstation
using Cartiscope™ (ArthroVision Inc., Montreal, Quebec,
Canada), as previously described [4, 32, 33]. The segmen-
tation of the cartilage-synovial interfaces was carried out
Table 1 Participant characteristics
Mean (SD)
n = 153
Gender 48 % female
Age (years) 62.2 (7.0)
BMI (kg/m2) 27.8 (4.7)
Any radiographic OA (%) 56.0
Osteophyte, any site (%) 9.2
Medial JSW (mm) 4.73 (0.97)
Lateral JSW (mm) 6.76 (1.37)









Annual change in joint space width:
Medial (mm) −0.05 (0.16)
Medial (%) −1.2 (3.9)
Lateral (mm) −0.12 (0.24)
Lateral (%) −1.8 (3.9)
Medial cartilage volume (tibia + femur, μL) 6296 (1523)
Lateral cartilage volume (tibia + femur, μL) 7080 (1671)
Annual change in cartilage volume:
Medial (μL) −134 (202)
Medial (%) −2.1 (3.0)
Lateral (μL) −106 (165)
Lateral (%) −1.6 (2.5)
Meniscal extrusions
Medial – present at baseline (%) 16.3
Medial – worsening extrusion (%) 9.2
Lateral – present at baseline (%) 2.0
Lateral – worsening extrusion (%) 0.7
Meniscal tears
Medial – present at baseline (%) 98.0
Medial – worsening tear (%) 10.5
Lateral – present at baseline (%) 96.7
Lateral – worsening tear (%) 15.0
Cartilage defects
Medial - present at baseline (%) 23.5
Medial - worsening (%) 37.7
Lateral - present at baseline (%) 21.6
Lateral - worsening (%) 36.4
Table 1 Participant characteristics (Continued)
Cartilage thickness (average, tibia & femur) (n = 67)
Medial (mm) 3.07 (0.41)
Lateral (mm) 3.33 (0.41)
Annual change in cartilage thickness
Medial (mm) −0.17 (0.27)
Medial (%) −6.04 (8.45)
Lateral (mm) −0.26 (0.3)
Lateral (%) −8.12 (8.69)
Change in cartilage and meniscal extrusion is over a time period of 2.4 years
Change in joint space width is over a time period of 5 years
Right knees only
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using a semi-automatic method under reader supervision,
and with corrections when needed. Cartilage volume was
evaluated directly from a standardized view of 3D cartilage
geometry as the sum of elementary volumes. The CV was
approximately 2 % [32]. The cartilage volume assessment
was done for the medial and lateral condyles delineated by
the Blumensaat’s line [33].
Meniscal extrusion and tears were assessed using the
T1-weighted fat suppressed sequences described earlier
[4]. Anterior and posterior horns of the menisci were
scored using the sagittal views and the body of the me-
nisci using reconstructed coronal views. The proportion
of the menisci affected by extrusion was measured
separately on the medial and lateral edges of the tibiofe-
moral joint space using a semi-quantitative scale. The
extent of meniscal extrusion, excluding osteophytes, was
evaluated for the anterior, middle, and posterior horns of
the menisci in which 0 = no extrusion, 1 = partial extru-
sion and 2 = complete extrusion with no contact with
the joint space (severe) [4]. The extent of meniscal tears
were assessed using the following scale: 0 = no damage;
1 = one of three meniscal areas involved (anterior, mid-
dle, and posterior horns); 2 = two of three areas involved;
3 = all three areas involved [4]. Change in meniscal tears
were classified as improvement or no change if scores
were unchanged or improved at either tibia or femur, or
classified as worsening if scores increased. Reliability
was excellent; intra- and inter-observer correlation
coefficients ranged from 0.86–0.96 [22].
Mean cartilage thickness for each of four regions
(femur facing the medial tibia, femur facing the lateral
tibia, medial tibia and lateral tibia) was assessed using
custom semi-automated segmentation software, and was
calculated as the mean distance from inner to outer
surface. This was done from a sample of uniformly
spaced points over the entire cartilage-covered surface.
Reliability was excellent: intra–observer reproducibility
for mean intensity in each region was less than 1.5 %,
with a coefficient of variation <2.9 % [34].
Cartilage defects were assessed by a trained observer
at the medial tibial, medial femoral, lateral tibial, and lat-
eral femoral sites, using the T1-weighted fat suppressed
sequences described earlier, and as previously described
[8]: grade 0 = normal cartilage; grade 1 = focal blistering
and intracartilaginous low-signal intensity area with an
intact surface and base; grade 2 = irregularities on the sur-
face or base and loss of thickness <50 %; grade 3 = deep
ulceration with loss of thickness >50 %; and grade 4 = full-
thickness chondral wear with exposure of subchondral
bone. ICCs ranged from 0.89–0.94 for intra-observer
reliability. These were dichotomised into none (grades 0
and 1 (normal/focal blistering)) or any defects (grades 2
and above). Change in cartilage defects were classified as
improvement or no change if scores were unchanged or
improved on the 0–4 scale at either tibia or femur, or
classified as worsening if scores increased.
Statistical analysis
We used Stata 12.1 (Stata Corp LP) for statistical
analyses. Statistical significance was set as a p value
of ≤0.05 (two tailed). Linear regression was used to
assess the association between change in cartilage
volume, meniscal extrusions, meniscal tears over
2.4 years and change in JSW over 5 years. R2 values
for univariable models are the R2 statistic from the
linear regression. R2 values for multivariable models
are the squared semipartial correlations for each indi-
vidual predictor in the multivariable model, which
represent the proportion of variance in the outcome
that is explained by the individual predictor only.
Total R2 is the sum of the squared semipartial
correlations for individual predictors, and is given by
Fig. 1 A representative MR image of cartilage segmentation. The volumes of individual cartilage plates (medial tibia and lateral tibia) were isolated
from the total volume by manually drawing disarticulation contours around the cartilage boundaries on a section by section basis, before being
re-sampled for 3-D rendering
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the adjusted R2 statistic (adjusted for degrees of
freedom) in the multivariable linear regression.
Results
A total of 153 participants (48 % female, mean age
62 years, [range 51–79]) had adequately aligned radio-
graphs (206 /307 pairs), complete MR imaging, and
radiograph data of the knee at baseline and follow up.
Baseline characteristics of this sample (n = 153) were
similar to the overall TASOAC population (n = 1099)
(age 62.2 vs 63.2 years, p = 0.14; sex 48 % female vs 49 %
female, p = 0.75; BMI 27.8 vs 27.9, p = 0.84) (Table 1).
Half of the participants (56 %, n = 84) had at least grade 1
radiographic OA at baseline, defined as either JSN or pres-
ence of osteophytes using the OARSI atlas [28]. Medial
and lateral cartilage volume significantly reduced over
time (medial −134.3 μL/year (95 % CI −166.6 to −102.0),
lateral −106.2 μL/year, (95 % CI −132.5 to −79.9), as was
JSW (medial −0.05 mm/year (95 % CI −0.08 to −0.03),
lateral −0.12 mm/year, (95 % CI −0.16 to −0.08). Although
the majority of participants demonstrated a decrease in
cartilage volume over time, JSW both decreased and
(Fig. 2). In the medial compartment, 67 % of participants
had a decrease in JSW, 5 % stayed the same, and 28 %
increased. Similar values were found for the lateral
compartment (73 % had a decrease in JSW, 2.6 % stayed
the same, and 24 % increased).
Change in cartilage volume over 2.4 years was a
significant predictor of change in JSW over 5 years in
univariate analyses (R2 = 4.4 %, p = 0.009 medially; R2 =
4.9 %, p = 0.006 laterally) (Table 2, Fig. 2a and b). How-
ever, in multivariable analysis, change in cartilage
volume was a significant predictor of change in JSW
only in the lateral compartment (R2 4.8 %, p = 0.007
laterally; R2 2.2 %, p = 0.064 medially) (Table 2).
New or worsening meniscal extrusions (ME) occurred
in 14 cases (9.2 %) medially and 1 case (0.66 %) laterally.
Only the medial data was used in the analysis due to the
small number of lateral ME. Of these meniscal extru-
sions, 9 were none to partial, 3 partial to complete and 2
none to complete extrusion. In unadjusted analyses,
change in medial JSW was greater in individuals with
new or worsening meniscal extrusions (Table 2, Fig. 3).
In multivariable analyses, new or worsening meniscal
extrusions over 2.4 years predicted change in JSW over
5 years at the medial tibial (R2 3.1 %, p = 0.031) and
medial femur (R2 3.2 %, p = 0.024) sites, and was stron-
gest in participants with radiographic OA (OARSI grade
≥1) (R2 = 6.2 %, p = 0.017), but did not reach statistical
significance in the whole population at both sites (R2
2.4 %, p = 0.053), after adjustment for change in meniscal
tears and cartilage defects. When predictive validity of
both change in cartilage volume and ME for JSW was
considered, they were additive (ie combined R2 = 8.3 %
in those with radiographic OA).
The addition of cartilage defects or meniscal tears to
the model did not reach statistical significance medially
or laterally, or within any subgroup.
We repeated analyses using another marker of cartilage
assessed in a subset of this cohort: cartilage thickness
(Table 3). This data suggests that associations between
change in cartilage thickness and change in JSW are of
similar or lesser magnitude to change in cartilage volume
loss and change in JSW. Similarly, total R2 in models
assessing change in cartilage thickness (Table 3) is similar
to, or less than values for models assessing change in
cartilage volume (Table 2). Data on study participants with
ROA are not shown as the number of included partici-
pants is too small (n = 40).
Fig. 2 Scatterplots showing the association between change in joint
space width (JSW) and change in cartilage volume (n = 153 medial,
n = 152 lateral). In both compartments, cartilage volume decreased
in 117 participants each of a and b, but in 29 in a and 26 in b JSW
increased despite a decrease in cartilage volume. a Medial compartment:
there is a significant negative correlation, with R2 = 4.4 %, p= 0.009
(unadjusted). b Lateral compartment: there is a significant negative
correlation, with R2 = 4.9 %, p= 0.006 (unadjusted)
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Sensitivity analyses
X-ray is weight bearing, but MRI is not; therefore we
further adjusted for BMI. This increased R2 values for
change in medial joint space width by small amounts:
3.0 % vs 2.2 % for total cartilage, and 3.0 % vs 2.4 % for
meniscal extrusion; and 3.8 % vs 2.1 % for total cartilage,
and 6.8 % vs 6.2 % for meniscal extrusion in people with
radiographic OA. R2 for change in cartilage volume,
meniscal extrusion and BMI were 8.3 and 17.1 % for
these models.
JSN in one compartment might affect change in
another; therefore we assessed change in medial JSN in
participants without lateral JSN at baseline (n = 126).
Total R2 values increased by a small amount (7.7 % vs
5.1 %), but R2 values for total cartilage volume were
similar (R2 = 1.8 % vs 2.2 %). R2 values for meniscal
extrusion increased in magnitude (R2 = 4.4, p = 0.02 vs
R2 = 2.4 %, p = 0.053), reaching statistical significance.
Discussion
In this 5 year longitudinal study of a population based
cohort, both JSW and cartilage volume decreased signifi-
cantly over time. Associations between cartilage volume
loss and change in JSW at both medial and lateral
compartments were weak and did not reach statistical
significance at all sites. Associations were consistent in
magnitude, explaining 2–13 % of the variance regardless
of measurement site or stratified analysis; although not
all of these attained statistical significance. The strength
of the associations between ME and change in JSW was
similar to the associations between change in cartilage
volume and change in JSW, and was strongest in those
with radiographic OA. Overall, over 80 % of the
variation in JSW change amongst individual study par-
ticipants remains unexplained, possibly due to measure-
ment error.
Whilst we observed an association between change in
JSW and cartilage volume loss, the small magnitude of
the association suggests that change in JSW over 5 years
provides only a very limited reflection of change in
cartilage volume over 2.4 years. Unlike radiographs, MRI
allows direct visualisation of the cartilage along with
other soft tissue structures, and in 3D compared to the
2D for radiographs. MR imaging has been validated in
cadaveric studies [35], and has demonstrated a direct link
with clinical outcomes such as joint replacement [36].
New or worsening cases of meniscal extrusion were
uncommon in our cohort, as previously reported [7].
However, ME contributed a similar or larger amount to
change in JSW as cartilage volume change at the medial
compartment. Predictive validity of both cartilage volume
change and ME for change in JSW was additive, but not
entirely independent. In participants with radiographic
OA, ME was a stronger predictor than change in cartilage
volume for change in JSW at the medial compartment.
These changes were observed in relatively small numbers
of participants, with only nine participants (5.8 %) having
radiographic OA and ME. However, this data is consistent
with studies using categorical measures of cartilage and
including larger numbers of participants with OA [7].
Adding change in meniscal tears to the multivariable
model added minimal additional explanatory power, and
did not reach statistical significance at any site or within
any subgroup. The proportion of variance explained by
cartilage defects were similar to that explained by
change in cartilage volume in some subgroups, but the
Fig. 3 Mean change in joint space width stratified by meniscal extrusion. In participants with incident meniscal extrusion at 2.4 years there was a
significantly greater decrease in JSW over 5 years (unadjusted)
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effect did not reach statistical significance in any groups
or sites, and the magnitude of the effect was less than
meniscal extrusion. Additivivity of factors is limited as
increases in R2 were modest.
Repeating the analysis using another assessment
method for cartilage (average thickness) yielded even
weaker associations.
In this study, more than 85 % of change in JSW over
time was unexplained by cartilage volume loss, change in
meniscal tears, meniscal extrusions or change in cartilage
defects. Additionally, the fact that we had to exclude 1/3
of radiographs (>2 mm difference in alignment between
films) despite a standardised protocol also suggests the
weakness of change in JSW as a measurement over time.
In addition to the factors we measured, the large
proportion of unexplained variance could be partially
attributed to measurement error due to artefacts in
positioning study participants for x-ray. We minimised
this through our analysis design, by limiting x-ray data to
those whose tibial inter rim distance was ≤2 mm between
phase 1 and phase 3 films [37]. Reading of the films them-
selves is unlikely to add much measurement error, as
reproducibility was excellent. Further adjustment for BMI
suggests that BMI is not the major source of unexplained
variance. Overall, measurement error due to technical
issues remains the most likely explanation given that a
substantial proportion of subjects actually increased their
JSW over 5 years which is unlikely to be physiologic
(unless there is greater cartilage loss in the other compart-
ment). The current FDA and EMEA guidelines accept
slowing, cessation or reversal of JSN using conventional
radiographs as a structural endpoint for pharmaceutical
trials of OA therapies, particularly when accompanied by
symptom improvement [3]. However, this study raises the
question of whether x-ray measures of JSW should remain
the gold standard outcome measure in clinical trials, or
Table 2 Association between change in cartilage volume, and new or worsening meniscal extrusions, meniscal tears, and cartilage
defects over 2.4 years; and change in joint space width over 5 years
Population Change in.. Medial joint space width Lateral joint space width
Univariable Multivariablea Univariable Multivariablea
All participants Tibial + femoral cartilage volume R24.4 %, p = 0.009 R2 2.2 %, p = 0.064 R24.9 %, p = 0.006 R24.8 %, p = 0.007
(n = 151 medially, Meniscal extrusion R24.3 %, p = 0.01 R2 2.4 %, p = 0.053 NA NA
n = 150 laterally) Meniscal tears R2 0.19 %, p = 0.60 R2 0.0 %, p = 0.97 R2 1.4 %, p = 0.15 R2 1.2 %, p = 0.18
Cartilage defects (tibia + femur) R2 1.4 %, p = 0.15 R2 0.7 %, p = 0.29 R2 0.26 %, p = 0.54 R2 0.01 %, p = 0.90
Total R2 7.7 % Total R2 6.2 %
Subgroup: cartilage measurement site
Tibia Tibial cartilage volume R2 1.7 %, p = 0.11 R2 0.8 %, p = 0.26 R2 3.34 %, p = 0.024 R23.8 %, p = 0.017
(n = 151) Meniscal extrusion R24.3 %, p = 0.01 R23.1 %, p = 0.031 NA NA
Meniscal tears R2 0.19 %, p = 0.60 R2 0.01 %, p = 0.91 R2 1.35 %, p = 0.15 R2 1.3 %, p = 0.16
Tibial cartilage defects R2 0.23 %, p = 0.56 R2 0.02 %, p = 0.85 R2 0.03 %, p = 0.83 R2 0.3 %, p = 0.52
Total R2 5.1 % Total R2 5.1 %
Femur Femoral cartilage volume R23.8 %, p = 0.016 R2 1.8 %, p = 0.095 R2 1.72 %, p = 0.11 R2 1.5 %, p = 0.13
(n = 150) Meniscal extrusion R24.3 %, p = 0.01 R23.2 %, p = 0.024 NA NA
Meniscal tears R2 0.19 %, p = 0.6 R2 0.04 %, p = 0.80 R2 1.35 %, p = 0.15 R2 1.2 %, p = 0.19
Femoral cartilage defects R23.0 %, p = 0.035 R2 2.2 %, p = 0.063 R2 2.26 %, p = 0.07 R2 2.2 %, p = 0.07
Total R2 9.0 % Total R2 4.9 %
Subgroup:Radiographic
OA of OARSI grade ≥1
(n = 85)
Tibial + femoral cartilage volume R27.8 %, p = 0.01 R2 2.1 %, p = 0.16 R2 3.0 %, p = 0.11 R2 3.3 %, p = 0.096
Meniscal extrusion R211.2 %, p = 0.002 R26.2 %, p = 0.017 NA NA
Meniscal tears R2 0.02 %, p = 0.91 R2 0.4 %, p = 0.53 R2 1.38 %, p = 0.28 R2 1.9 %, p = 0.21
Tibial + femoral
cartilage defects
R2 4.5 %, p = 0.051 R2 2.3 %, p = 0.14 R2 0.49 %, p = 0.53 R2 1.1 %, p = 0.33
Total R2 16.7 % Total R2 5.6 %
Results obtained using linear regression
aAdjusted for change in cartilage volume, change in meniscal extrusion, change in meniscal tears or change in cartilage defects where applicable
NA indicates not applicable (incidence of meniscal extrusion very low)
Bold text indicates statistically significant result (p ≤ 0.05)
R2 for univariable models is the proportion of variance explained provided (R2) for the linear regression
R2 for multivariable models is the proportion of variance explained for individual components of the multivariable model (semipartial R2)
Total R2 is the proportion of variance explained for the entire multivariable model
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whether cartilage loss using MRI should be adopted, as is
being proposed by others [38, 39].
There have been a number of longitudinal studies compar-
ing cartilage volume loss and JSW [17, 20–23, 32, 40, 41].
Most focus on the medial compartment of the tibiofe-
moral joint in populations with OA [20, 21, 23, 40].
A cross-sectional association between meniscal extru-
sion or positioning and JSW has previously been
described [4, 7, 22, 42], with one study demonstrating
a strong association between medial meniscal subluxation
and JSW (r = 0.56) [43], and another showing that menis-
cal position and change in cartilage score both contributed
to JSW over 30 months [7]. However, our study is the first
to our knowledge that has investigated associations over
5 years, and has used continuous measures of both cartil-
age volume and JSW.
There are a number of limitations in this study. The
gold standard for X-ray protocols have changed since
our study began in 2002, based on evidence suggesting
that newer methods may be more sensitive to change in
JSW [44]. However, the method we used is a sensitive
measure of joint space loss over time [45], and studies
have shown no advantage of one flexion x-ray protocol
over another [46, 47] although there are no head to head
studies [3]. Additionally, the rates of cartilage loss are
lower than might be expected in a population of study
participants who all had knee OA. However, sensitivity
in our community–based sample [18] is comparable
[48], or better [17] than SRM’s from other samples.
Additionally, we conducted a sensitivity analysis, limiting
the data to those with radiographic OA; while the
magnitude of the associations increased, the conclusions
Table 3 Association between change in cartilage thickness, and new or worsening meniscal extrusions, meniscal tears, and cartilage
defects over 2.4 years; and change in joint space width over 5 years (n = 65)
Medial JSNa Lateral JSN
Unadjusted Adjusted Unadjusted Adjusted
Tibial and femoral cartilage
combined
Tibial + femoral cartilage thickness R2 2.4 %, p =
0.21
R2 3.6 %, p =
0.14
R2 0.2 %, p =
0.71
R2 0.0 %, p =
0.91
New or worsening meniscal
extrusion
R2 1.5 %, p =
0.32
R2 0.4 %, p =
0.62
N/A N/A
Worsening meniscal tears R2 0.0 %, p =
0.99
R2 0.1 %, p =
0.78
R2 1.9 %, p =
0.27
R2 1.3 %, p =
0.38
Worsening cartilage defects R2 2.1 %, p =
0.25
R2 1.1 %, p =
0.41
R2 1.0 %, p =
0.43
R2 0.9 %, p =
0.46
Total R2 = 6.2 % Total R2 = 2.3 %
Subgroup: cartilage measurement site
Tibial cartilage alone Tibial cartilage thickness R2 2.5 %, p =
0.33
R2 2.5 %, p =
0.21
R2 0.7 %, p =
0.52
R2 1.7 %, p =
0.30
New or worsening meniscal
extrusion
R2 1.5 %, p =
0.32
R2 0.8 %, p =
0.48
NA NA
Worsening meniscal tears R2 0.0 %, p =
0.99
R2 0.2 %, p = 0.7 R2 1.9 %, p =
0.27
R2 1.3 %, p =
0.37
Worsening cartilage defects R2 2.1 %, p =
0.25
R2 1.3 %, p =
0.37
R2 1.0 %, p =
0.43
R2 1 %, p = 0.43
Total R2 = 5.1 % Total R2 = 3.9 %
Femoral cartilage alone Femoral cartilage thickness R2 2.3 %, p =
0.22
R2 3.3 %, p =
0.15
R2 1.9 %, p =
0.27
R2 1.6 %, p =
0.31
New or worsening meniscal
extrusion
R2 1.5 %, p =
0.32
R2 0.3 %, p =
0.65
N/A N/A
Worsening meniscal tears R2 0.0 %, p =
0.99
R2 0.1 %, p =
0.86
R2 0.4 %, p =
0.27
R2 1.6 %, p =
0.31
Worsening cartilage defects R2 2.1 %, p =
0.25
R2 1.0 %, p =
0.44
R2 1.0 %, p =
0.43
R2 1.1 %, p =
0.40
Total R2 = 5.9 % Total R2 = 3.9 %
Results obtained using linear regression
aAdjusted for change in cartilage thickness, change in meniscal extrusion, change in meniscal tears or change in cartilage defects where applicable
NA indicates not applicable (incidence of meniscal extrusion very low)
Bold text indicates statistically significant result (p ≤ 0.05) (No associations were statistically significant)
R2 for univariable models is the proportion of variance explained provided (R2) for the linear regression
R2 for multivariable models is the proportion of variance explained for individual components of the multivariable model (semipartial R2)
Total R2 is the proportion of variance explained for the entire multivariable model
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did not change. Another potential criticism is the
method used to evaluate meniscal extrusion. Extrusion
was examined on sagittal MRI views, and using the same
sequence as cartilage so as to limit the time the partici-
pant spent in the MRI scanner. Coronal views may be
more sensitive [7], and T2 sequences are better for
visualising menisci [4]. Therefore, it can be hypothesised
that these analyses may underestimate of the contribu-
tion of meniscal extrusion to change in JSW. However,
this has never been proven by a head to head study.
Additionally, the follow up period for Xrays (5 years)
and MRI (2.4 years) was not the same. However, as
radiograph–assessed measures of OA progression are
less sensitive and require longer periods of observation,
this allows additional time for changes that are visible
on MR but not on radiographs to become visible, and
we do not consider that this affects the conclusions of
these analyses. Furthermore, in this study we were only
able to examine the sub group of 153 participants in the
TASOAC cohort that had full x-ray and MRI data and
were adequately aligned. However, because there were
no significant differences in baseline factors including
demographic factors, anthropometry or imaging abnor-
malities between the participants included in this study
and the whole cohort, this suggests that the validity has
not been compromised.
Conclusions
Change in cartilage volume over 2.4 years only weakly
predicted change in JSW over 5 years in participants
from a community cohort. ME contributed similarly to
cartilage volume change to change in JSW in the medial
compartment in all study participants, but a greater
amount in those with radiographic OA, while changes in
meniscal tears and cartilage defects made minimal
contributions to proportion of variance explained. Since
MRI examines cartilage directly while radiographs exam-
ine it indirectly, these results cast doubt on the validity
of using JSW as a proxy measure of loss of cartilage
volume. This suggests that it is time to re-evaluate this
as the choice of primary outcome measure for clinical
trials of disease modifying drugs in OA.
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